Augmedix to Participate at the 11th Annual LifeSci Partners Corporate Access Event
04 January 2022 - 12:00AM
Augmedix, Inc. (Nasdaq: AUGX), a leading provider of virtual
medical documentation and live clinical support, today announced
the company will be participating in the upcoming 11th Annual
LifeSci Partners Corporate Access Event, being held virtually from
January 5 to 7, 2022.
Manny Krakaris, CEO of Augmedix, will participate in a panel
discussion titled, “Telehealth & Digital Medicine: At the
Crossroads of Virtual Care,” on Thursday, January 6, 2022, at 8:30
a.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation on the “Investor Relations”
section of the company’s website at: https://ir.augmedix.com.
About Augmedix Augmedix, Inc. (Nasdaq: AUGX)
provides automated medical documentation and data services to large
healthcare systems and physician practices, supporting medical
offices, clinics, hospitals, emergency departments, and
telemedicine nationwide. The Company’s Ambient Automation Platform
converts the natural conversation between physicians and patients
into timely and comprehensive medical notes and performs a suite of
related data services. These services relieve physicians of
administrative burdens to enable more time for patient care.
Augmedix’s proprietary platform uses automatic speech recognition,
natural language processing, and clinical datasets to capture the
ambient visit conversation and generate a structured medical note.
The structured medical note data is then used to deliver additional
data services. Quality is assured by trained medical documentation
specialists. To learn more about Augmedix, visit augmedix.com.
Investors:Caroline PaulGilmartin
Groupinvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Apr 2023 to Apr 2024